ConductScience.org, home

Paper277239

Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.

Sheldon PW and 1 other. Br J Cancer Suppl, 1978. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. Papers, record 277239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/277239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.
PubMed
Journal
Br J Cancer Suppl
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sheldon PWP W
2Fowler JFJ F

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neoplasms, ExperimentalMajor topic
NitroimidazolesMajor topic
Radiation-Sensitizing AgentsMajor topic
Animals
Mice
Oxygen
Radiotherapy Dosage
Skin

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1304049Radioprotection by pentobarbitone sodium of a murine tumour in vivo.Int J Radiat Biol Relat Stud Phys Chem Med1977https://conductscience.org/library/papers/304049PubMed
2871367Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.Br J Cancer1977https://conductscience.org/library/papers/871367PubMed
3861451The effect of radiation on tumour growth delay, cell survival and cure of the animal using a single tumour system.Br J Radiol1977https://conductscience.org/library/papers/861451PubMed
4856238Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.Br J Cancer1977https://conductscience.org/library/papers/856238PubMed
54451633Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.Br J Cancer1974https://conductscience.org/library/papers/4451633PubMed
64545175Skin reactions in mice after multifraction x-irradiation.Int J Radiat Biol Relat Stud Phys Chem Med1974https://conductscience.org/library/papers/4545175PubMed
7776494Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.Clin Radiol1976https://conductscience.org/library/papers/776494PubMed
8959489Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells.Radiat Res1976https://conductscience.org/library/papers/959489PubMed
91265229The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation.Radiat Res1976https://conductscience.org/library/papers/1265229PubMed
101276579Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.Br J Radiol1976https://conductscience.org/library/papers/1276579PubMed
111257411The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.Radiat Res1976https://conductscience.org/library/papers/1257411PubMed
121178881Hypoxic sensitizers: radiobiological studies at the cellular level.Radiology1975https://conductscience.org/library/papers/1178881PubMed
131174445Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results.Br J Cancer1975https://conductscience.org/library/papers/1174445PubMed
145774088Dose, time and fractionation: a clinical hypothesis.Clin Radiol1969https://conductscience.org/library/papers/5774088PubMed
156057668The relative effects of fast neutrons and x rays on tumour and normal tissue in the rat. I. Single doses.Br J Radiol1967https://conductscience.org/library/papers/6057668PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
30202000Transferrin as a thermosensitizer in radiofrequency hyperthermia for cancer treatment.Sci Rep2018https://conductscience.org/library/papers/30202000PubMed
7150492A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.Br J Cancer1982https://conductscience.org/library/papers/7150492PubMed
7000125Is any single in situ assay of tumour response adequate?Br J Cancer Suppl1980https://conductscience.org/library/papers/7000125PubMed
1931628A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer.Br J Cancer1991https://conductscience.org/library/papers/1931628PubMed
526430The quantitative response of human tumours to radiation and misonidazole.Br J Cancer1979https://conductscience.org/library/papers/526430PubMed
277243Sensitization of mouse tumours using fractionated X-irradiation.Br J Cancer Suppl1978https://conductscience.org/library/papers/277243PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/277239

GET https://conductscience.org/api/papers/v1/277239/authors